Anavex Life Sciences Corp... (AVXL)

AI Score

Unlock

9.40

-0.05 (-0.53%)

At close: Apr 25, 2025, 3:59 PM

9.52

1.28%

After-hours: Apr 25, 2025, 05:34 PM EDT

Anavex Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015
Net Income	-46.49M	-43M	-41.53M	-40.59M	-43.16M	-47.5M	-51.65M	-52.74M	-50.07M	-47.98M	-45.41M	-43.22M	-40.94M	-37.91M	-32.16M	-28.46M	-27.54M	-26.28M	-24.19M	-24.78M	-25.55M	-26.29M	-28.21M	-23.98M	-20.73M	-17.45M	-16.81M	-17.58M	-14.37M	-13.46M	-14.82M	-13.45M	-13.93M	-14.74M	-13.58M	-15.58M	-15.28M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	506.00	755.00	1K	1.25K	995.00	994.00	995.00
Stock-Based Compensation	9.21M	9.44M	10.61M	11.99M	13.31M	16.37M	19.23M	19.35M	19.82M	18.38M	15.49M	13.79M	11.2M	8.23M	5.74M	4.7M	4.55M	4.88M	5.45M	5.44M	5.63M	6.43M	6.69M	7.13M	6.46M	5.52M	5.14M	4.63M	4.37M	4.14M	6.8M	5.87M	5.13M	5.06M	2.65M	2.65M	2.44M
Other Working Capital	295K	-2.67M	715.32K	-100.12K	1.67M	2.01M	4.57M	3.51M	3.07M	6.28M	3.1M	2.11M	3.3M	-1.46M	-2.74M	-1.73M	-1.53M	-349.2K	682.99K	-1.84M	193.53K	1.3M	1.48M	2.22M	1.14M	-646K	950.7K	1.42M	596.09K	382.81K	150.86M	151.09M	151.26M	152.04M	876.63K	945.38K	1.03M
Other Non-Cash Items	3.45M	6.61M	6.55M	10.03M	7.42M	9.05M	11.03M	11.19M	17.89M	13.35M	14.5M	13.96M	8.27M	8.25M	5.13M	2.41M	1.09M	465.72K	492.25K	-2.01M	-1.18M	302.44K	680.56K	2.64M	1.91M	38.23K	1.75M	1.89M	1.19M	983.93K	-1.14M	-1.07M	-1.14M	-145.57K	1.24M	3.85M	4.49M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-60.79K	-61.05K	-58.14K	-58.14K	14.05K	117.32K	532.54K
Change in Working Capital	1.67M	2.75M	971.25K	-3.87M	-309.09K	2.5M	5.6M	7.16M	3.72M	5.36M	2.05M	1.09M	3.72M	-706.44K	-2.55M	-1.72M	-441.45K	116.52K	1.14M	-1.71M	-202.3K	1.3M	1.48M	2.22M	1.14M	-646K	950.7K	1.42M	596.09K	382.81K	-544.1K	-307.4K	-138.95K	640.07K	876.63K	945.38K	1.03M
Operating Cash Flow	-35.61M	-30.81M	-30M	-32.48M	-29.31M	-27.79M	-25.98M	-25.38M	-26.53M	-24.24M	-27.87M	-28.34M	-26.01M	-30.38M	-28.96M	-25.49M	-23.43M	-21.29M	-17.57M	-21.02M	-20.09M	-18.53M	-20.05M	-14.63M	-13.12M	-12.58M	-10.72M	-11.61M	-9.48M	-9.02M	-8.69M	-7.94M	-9.14M	-9.24M	-8.81M	-8.01M	-6.78M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-34.76K	-34.76K	-34.76K	-34.76K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	8.52M	7.87M	8.65M	8.2M	1.11M	1.05M	181.18K	509.09K	76.29K	303.31K	2.53M	135.03K	513.89K	23.65K	-2.58M	-539.66K	-667.22K	-403.76K	-24.51K	n/a	n/a	-50K	-101.13K	-120.19K	-151.13K	-101.13K	-50K	-30.94K	n/a	n/a	n/a	n/a	-125.06K	n/a	n/a	n/a	125.06K
Financial Cash Flow	12.62M	11.97M	13.94M	18.4M	29.45M	29.65M	27.6M	25.5M	19.01M	21.29M	23.51M	105.82M	129.8M	153.24M	158.9M	74.78M	43.33M	28.35M	23.94M	28.13M	26.84M	17.78M	15.47M	8.43M	5.79M	8.07M	11.76M	13.91M	16.37M	27.27M	23.75M	19.34M	16.45M	3.13M	10.57M	13.65M	13.65M
Net Cash Flow	-22.99M	-18.84M	-16.06M	-14.08M	143.04K	1.87M	1.62M	124.29K	-7.52M	-2.95M	-4.36M	77.48M	103.79M	122.86M	129.94M	49.3M	19.9M	7.06M	6.37M	7.11M	6.74M	-745.01K	-4.58M	-6.2M	-7.33M	-4.51M	1.03M	2.31M	6.89M	18.25M	15.07M	11.4M	7.31M	-6.1M	1.77M	5.64M	6.87M
Free Cash Flow	-35.61M	-30.81M	-30M	-32.48M	-29.31M	-27.79M	-25.98M	-25.38M	-26.53M	-24.24M	-27.87M	-28.34M	-26.01M	-30.38M	-28.96M	-25.49M	-23.43M	-21.29M	-17.57M	-21.02M	-20.09M	-18.53M	-20.05M	-14.63M	-13.12M	-12.58M	-10.72M	-11.61M	-9.48M	-9.02M	-8.69M	-7.94M	-9.14M	-9.24M	-8.81M	-8.01M	-6.78M